Malignant Musculoskeletal Neoplasm

Malignant Musculoskeletal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived113 of 113show fewer
→ investigated in trials for	Doxorubicinsmall molecule 32 trials (11 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 29 trials (15 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall molecule 24 trials (13 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 21 trials (9 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall molecule 20 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	20	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 17 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Dactinomycinother 13 trials (8 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Trabectedinsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Topotecansmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinorelbinesmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Dacarbazinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Busulfansmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Epirubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ensartinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganitumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ivosidenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Letrozolesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lurbinectedinsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Mocetinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ridaforolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Samotolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Selpercatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Tazemetostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Thiotepasmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Tipifarnibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vemurafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alemtuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dinutuximab Betamonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Elacestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Fruquintinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Fulvestrantsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Hyperthermic Intraperitoneal Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imiquimodsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaratumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Prexasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ribociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Selumetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sonidegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tretinoinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vimseltinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Musculoskeletal Neoplasm	1	Observed	clinicaltrials	graph →

Malignant Musculoskeletal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived113 of 113show fewer

→ investigated in trials for

Doxorubicinsmall molecule

32 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

29 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall molecule

24 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

21 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

20 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

17 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

17 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dactinomycinother

13 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

13 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

13 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trabectedinsmall molecule

11 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall molecule

8 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

6 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dacarbazinesmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Busulfansmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Epirubicinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Regorafenibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ensartinibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinib Hydrochloridesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganitumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ivosidenibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Larotrectinibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Letrozolesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lurbinectedinsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mocetinostatsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ridaforolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Samotolisibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selpercatinibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thalidomidesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tipifarnibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vemurafenibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afliberceptother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alectinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alemtuzumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvocidibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Berzosertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dinutuximab Betamonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elacestrantsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elimusertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fruquintinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Futibatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Hyperthermic Intraperitoneal Chemotherapy

→ investigated in trials for

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinib Mesylatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imiquimodsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lomustinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaratumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prexasertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selumetinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talimogene Laherparepvecgene therapy

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tanespimycinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tretinoinsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vimseltinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Malignant Musculoskeletal Neoplasm studied in …STUDIED_INderived10 of 465show all (up to 200)
→ studied in	NCT02893397NA · active not recruiting Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	Malignant Bone Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05691478Phase 2/Phase 3 · suspended A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	High Grade Osteosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06498648Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 465 trials mapped (176 active)	—	—	Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 465 trials mapped (176 active)	—	—	Uterine Corpus Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06865664Phase 1 · recruiting FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02923778Phase 2 · active not recruiting Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06308419Phase 1 · active not recruiting A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	Leiomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07193550Phase 2 · recruiting A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)	—	—	Bone Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 465 trials mapped (176 active)	—	—	Childhood Rhabdomyosarcoma	1	Observed	clinicaltrials	graph →

Malignant Musculoskeletal Neoplasm studied in …STUDIED_INderived10 of 465show all (up to 200)

→ studied in

NCT02893397NA · active not recruiting

Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

Malignant Bone Neoplasm

Observed

→ studied in

NCT05691478Phase 2/Phase 3 · suspended

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

High Grade Osteosarcoma

Observed

→ studied in

NCT06498648Phase 1/Phase 2 · recruiting

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 465 trials mapped (176 active)

—

Leiomyosarcoma

Observed

Uterine Corpus Leiomyosarcoma

→ studied in

NCT06524583Phase 2 · recruiting

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 465 trials mapped (176 active)

—

Observed

→ studied in

NCT06865664Phase 1 · recruiting

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

Rhabdomyosarcoma

Observed

→ studied in

NCT02923778Phase 2 · active not recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

Leiomyosarcoma

Observed

→ studied in

NCT06308419Phase 1 · active not recruiting

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

Leiomyosarcoma

Observed

→ studied in

NCT06441331Phase 1 · recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

Rhabdomyosarcoma

Observed

→ studied in

NCT07193550Phase 2 · recruiting

A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) · condition mapped ONTOLOGY_EXACT · 465 trials mapped (176 active)

—

Bone Sarcoma

Observed

Childhood Rhabdomyosarcoma

→ studied in

NCT03210714Phase 2 · active not recruiting

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 465 trials mapped (176 active)

—

Observed